Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OsrHSA in Decompensated Cirrhotic Ascites
NCT04835480Phase 2Recruiting
- Sponsor
- Wuhan Healthgen Biotechnology Corp.
- Start
- Mar 2021
- Primary completion
- Jun 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of OsrHSA in ascites, sponsored by Wuhan Healthgen Biotechnology Corp.. Started Mar 2021; status: recruiting.
02
Drugs
OsrHSA
03
Conditions
ascites
Beyond the preview
Go deeper on NCT04835480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04835480.